Institutional Ownership Madrigal Pharmaceuticals, Inc. (MDGL)
This table provides information about the institutional ownership of Madrigal Pharmaceuticals, Inc. (MDGL). We have compiled data on the 297 institutions that hold shares in the stock, with a total of 22 Million shares, which have been reported (via 13F filing form) to have a value of $6.83 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
43,032
shares
|
$13.4 Million
5.3% of portfolio
|
Q1 2024
Added 43.29%
|
|
Alp Invest Partners B.V.
Amsterdam, P7 |
Nov 08, 2024 Q3 2024 |
42,297
shares
|
$13.1 Million
6.43% of portfolio
|
Q3 2024
Reduced 50.0%
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
42,153
shares
|
$13.1 Million
0.01% of portfolio
|
Q1 2024
Reduced 58.42%
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
40,279
shares
|
$12.5 Million
0.0% of portfolio
|
Q3 2024
Added 165.06%
|
|
Gilder Gagnon Howe & CO LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
38,133
shares
|
$11.9 Million
0.1% of portfolio
|
Q3 2024
Reduced 0.64%
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
38,130
shares
|
$11.9 Million
0.01% of portfolio
|
Q3 2024
Reduced 31.58%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
37,660
shares
|
$11.7 Million
0.0% of portfolio
|
Q3 2024
Added 2392.39%
|
|
Tekla Capital Management LLC
|
Aug 10, 2023 Q2 2023 |
34,434
shares
|
$10.7 Million
0.31% of portfolio
|
Q2 2023
Added 175.89%
|
|
Handelsbanken Fonder Ab
|
Oct 04, 2024 Q3 2024 |
32,500
shares
|
$10.1 Million
0.03% of portfolio
|
Q3 2024
Added 2.85%
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
32,396
shares
|
$10.1 Million
0.04% of portfolio
|
Q3 2024
New holding
|
|
Vestal Point Capital, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
30,000
shares
|
$9.33 Million
0.48% of portfolio
|
Q3 2024
New holding
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Nov 13, 2024 Q3 2024 |
29,957
shares
|
$9.31 Million
0.01% of portfolio
|
Q3 2024
Reduced 16.04%
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
29,319
shares
|
$9.11 Million
0.0% of portfolio
|
Q3 2024
Reduced 1.07%
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
28,621
shares
|
$8.9 Million
0.0% of portfolio
|
Q3 2024
Added 78.19%
|
|
Emerald Advisers, LLC
|
Oct 29, 2024 Q3 2024 |
27,265
shares
|
$8.48 Million
0.24% of portfolio
|
Q3 2024
Reduced 71.82%
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
25,000
shares
|
$7.77 Million
0.0% of portfolio
|
Q3 2024
Added 0.81%
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
24,197
shares
|
$7.52 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.55%
|
|
Simplify Asset Management Inc.
New York, NY |
Nov 12, 2024 Q3 2024 |
23,305
shares
|
$7.24 Million
0.26% of portfolio
|
Q3 2024
Reduced 0.03%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
22,356
shares
|
$6.95 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.16%
|
|
California Public Employees Retirement System
Sacramento, CA |
Nov 13, 2024 Q3 2024 |
22,295
shares
|
$6.93 Million
0.0% of portfolio
|
Q3 2024
Added 0.15%
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 29, 2024 Q3 2024 |
21,687
shares
|
$6.74 Million
0.26% of portfolio
|
Q3 2024
Reduced 71.37%
|
|
Schroder Investment Management Group
London, X0 |
Nov 13, 2024 Q3 2024 |
20,842
shares
|
$6.48 Million
0.0% of portfolio
|
Q3 2024
Added 64.01%
|
|
Raymond James & Associates
St Petersburg, FL |
Oct 18, 2024 Q3 2024 |
19,433
shares
|
$6.04 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.37%
|
|
Hennion & Walsh Asset Management, Inc.
|
Oct 22, 2024 Q3 2024 |
18,917
shares
|
$5.88 Million
0.19% of portfolio
|
Q3 2024
Reduced 6.98%
|
|
International Biotechnology Trust PLC
London, X0 |
Nov 14, 2023 Q3 2023 |
18,300
shares
|
$5.69 Million
0.91% of portfolio
|
Q2 2023
New holding
|